SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001375151-20-000071
Filing Date
2020-05-05
Accepted
2020-05-05 16:05:58
Documents
16
Period of Report
2020-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zgnx-20200505.htm   iXBRL 8-K 50782
2 EX-99.1 a2020q1erex-991.htm EX-99.1 171013
8 LOGO zgnxlogo1.jpg GRAPHIC 22119
  Complete submission text file 0001375151-20-000071.txt   412686

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zgnx-20200505.xsd EX-101.SCH 2561
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zgnx-20200505_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zgnx-20200505_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zgnx-20200505_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zgnx-20200505_pre.xml EX-101.PRE 13188
13 EXTRACTED XBRL INSTANCE DOCUMENT zgnx-20200505_htm.xml XML 11538
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 20848825
SIC: 2834 Pharmaceutical Preparations